ACS Omega
(Sep 2023)
In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases
- Pitchayathida Mee-udorn,
- Kochakorn Phiwkaow,
- Ruchanok Tinikul,
- Kamonpan Sanachai,
- Somchart Maenpuen,
- Thanyada Rungrotmongkol
Affiliations
- Pitchayathida Mee-udorn
- Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok, Thailand
- Kochakorn Phiwkaow
- Department of Biochemistry, Faculty of Science, Burapha University, Chonburi, Thailand
- Ruchanok Tinikul
- Department of Biochemistry and Center for Excellence in Protein and Enzyme Technology, Faculty of Science, Mahidol University, Bangkok, Thailand
- Kamonpan Sanachai
- Department of Biochemistry, Faculty of Science, Khon Kaen University, Khon Kaen, Thailand
- Somchart Maenpuen
- Department of Biochemistry, Faculty of Science, Burapha University, Chonburi, Thailand
- Thanyada Rungrotmongkol
- Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok, Thailand
- DOI
-
https://doi.org/10.1021/acsomega.3c01309
- Journal volume & issue
-
Vol. 8,
no. 39
pp.
35580
– 35591
WeChat QR code